HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
NCT01298037 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 201
Last updated 2026-01-22
Summary
This is an ancillary to the NIDDK-sponsored Hepatitis B Research Network (HBRN) Study Cohort Study NCT01263587. This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study (NCT01263587).
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - lead OTHER
Principal Investigators
-
Kyong-Mi Chang, MD · University of Pennsylvania
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-02-01
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-01
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
NCT02412592 ·Status: UNKNOWN
-
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
NCT03546530 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Performance Evaluation of DxN HBV Assay
NCT03123159 ·Status: TERMINATED
-
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
NCT01369199 ·Status: TERMINATED ·Phase: PHASE3
-
Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection
NCT03248622 ·Status: COMPLETED
-
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
NCT05856890 ·Status: RECRUITING ·Phase: PHASE1
-
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients
NCT03777969 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
NCT06650852 ·Status: RECRUITING ·Phase: PHASE2
-
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
NCT06779864 ·Status: RECRUITING
-
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients
NCT01958229 ·Status: COMPLETED
-
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
NCT04028856 ·Status: COMPLETED
-
Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection
NCT06245291 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
NCT03357822 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
NCT00877149 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection
NCT04585789 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
NCT06777173 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
NCT00199732 ·Status: COMPLETED
-
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
NCT06668727 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
NCT05905458 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
NCT05769816 ·Status: RECRUITING ·Phase: PHASE2
-
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
NCT01581554 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients
NCT04133259 ·Status: UNKNOWN ·Phase: PHASE2